EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): C$0.17

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is C$0.18. In 2024 the company made an earnings per share (EPS) of C$0.19 an increase over its 2023 EPS that were of C$0.13.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	C$0.17	-7.99%
2024	C$0.19	42.43%
2023	C$0.13	8.77%
2022	C$0.12	-20.62%
2021	C$0.15	-26.59%
2020	C$0.21	27.24%
2019	C$0.16	28.41%
2018	C$0.13	20.04%
2017	C$0.11	31.21%
2016	C$0.08127	11.46%
2015	C$0.07291	36.27%
2014	C$0.05350	19.77%
2013	C$0.04467	18.05%
2012	C$0.03784	23.9%
2011	C$0.03054	26.9%
2010	C$0.02407	12.37%
2009	C$0.02142	56.6%
2008	C$0.01368	9.18%
2007	C$0.01253	114.48%
2006	C$0.005841	64.83%
2005	C$0.003544	35.55%
2004	C$0.002614	29.73%
2003	C$0.002015	19.86%
2002	C$0.001681	-2.71%
2001	C$0.001728	1.02%
2000	C$0.001711

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions